Casdin Private Growth Equity Fund, L.P.'s Net Worth

$3.47 Million

Estimate Recalculated Jul 31, 2025 12:11AM EST

Who is Casdin Private Growth Equity Fund, L.P.

Casdin Private Growth Equity Fund, L.P. has an estimated net worth of $3.47 Million. This is based on reported shares across multiple companies, which include Absci Corp, Tenaya Therapeutics, Inc., Verve Therapeutics, Inc., and STANDARD BIOTOOLS INC..

SEC CIK

Casdin Private Growth Equity Fund, L.P.'s CIK is 0001823061

Past Insider Trading and Trends

2021 was Casdin Private Growth Equity Fund, L.P.'s most active year for acquiring shares with 1 total transactions. Casdin Private Growth Equity Fund, L.P.'s most active month to acquire stocks was the month of May. 2021 was Casdin Private Growth Equity Fund, L.P.'s most active year for disposing of shares, totalling 1 transactions. Casdin Private Growth Equity Fund, L.P.'s most active month to dispose stocks was the month of May. 2021 saw Casdin Private Growth Equity Fund, L.P. paying a total of $0.00 for 620,571 shares, this is the most they've acquired in one year. In 2021 Casdin Private Growth Equity Fund, L.P. cashed out on 5,746,183 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Absci Corp

Investor
Updated Jul 28, 2021
Form 4
139.64%
4.50M
$16.00
$25.00M
Jul 28, 2021
7.72M
Purchase
Jul 26
Form 3
Jul 21, 2021
Showing 2 results

STANDARD BIOTOOLS INC.

Investor
Updated Aug 29, 2024
Form 4
0.46%
250.00K
$2.19
$546.75K
Aug 29, 2024
74.04M
Purchase
Aug 27
Form 4
0.70%
750.00K
$2.09
$1.55M
Aug 26, 2024
127.41M
Purchase
Aug 22 - Aug 26
Form 4
2.37%
1.20M
$1.59
$1.91M
Aug 16, 2024
71.79M
Purchase
Aug 14
Form 4
3.22%
1.58M
$1.62
$2.56M
Aug 13, 2024
70.59M
Purchase
Aug 09 - Aug 13
Form 4
1.11%
1.07M
$1.61
$1.72M
Aug 09, 2024
117.44M
Purchase
Aug 07 - Aug 08
Form 4
$2.05
Jun 21, 2024
67.84M
Acq/Dis
Jun 18
Form 4
0.22%
100.00K
$2.60
$260.00K
May 28, 2024
71.61M
Purchase
May 23
Form 4
1.32%
600.00K
$2.57
$1.54M
May 22, 2024
71.51M
Purchase
May 20 - May 22
Form 4
3.07%
1.35M
$2.56
$3.46M
May 17, 2024
70.91M
Purchase
May 15 - May 17
Form 4
398.58%
46.34M
$2.75
$127.43M
Mar 20, 2024
69.56M
Acquisition
Mar 18
Form 4
2.24%
251.40K
$2.57
$646.17K
Mar 06, 2024
23.09M
Purchase
Mar 04 - Mar 05
Form 4
13.99M
Jan 09, 2024
15.19M
Grant
Jan 05
Showing 12 results

Tenaya Therapeutics, Inc.

Investor
Updated Aug 04, 2021
Form 4
31.06%
850.00K
$15.00
$12.75M
Aug 04, 2021
3.59M
Purchase
Aug 03
Form 3
Jul 29, 2021
Showing 2 results

Verve Therapeutics, Inc.

Investor
Updated Jun 22, 2021
Form 4
-89.20%
-5.13M
Jun 22, 2021
620.57K
Options
Jun 21
Form 3
Jun 16, 2021
Showing 2 results